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E-mail address: ildi@civ.bio.unipd.it (I. Szabò).Recent evidence points to the crucial involvement of voltage-gated potassium channels (Kv) in
apoptotic volume decrease and in the regulation of apoptosis in several systems. We have recently
described the presence of a Kv channel, Kv1.3, in the mitochondria of lymphocytes. Expression of
the channel correlated with increased sensitivity to apoptotic stimuli. Mitochondrial Kv1.3 contrib-
utes to the apoptotic cascade in T lymphocytes by interacting with pro-apoptotic Bax resulting in
alteration of mitochondrial functional parameters and ultimately, in cytochrome c release. The pres-
ent review summarizes the current understanding of the function of Kv channels in apoptosis in
several cell types as well as the role of mitochondrial Kv1.3 in the regulation of cell death in
lymphocytes.
 2010 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Voltage-gated potassium channels
Voltage-gated K+ channels (VGKCs or Kv) are formed by four
subunits surrounding a central pore, each subunit containing six
transmembrane segments (S1–S6). S5 and S6 are connected by a
pore loop that contributes to both ion selectivity and gating (e.g.
[1]) while the positively charged S4 segment confers voltage sensi-
tivity [2–4]. The intracellular domains, including N and C-termini,
contain consensus sequences for phosphorylation and the N-termi-
nus determines interaction with other subunits or regulatory pro-
teins. Voltage-gated potassium channels comprise a large family of
channels (80 distinct potassium channel genes have been identi-
ﬁed in the human genome) that are found in both excitable and
non-excitable cells. They control the resting plasma membrane po-
tential and the frequency of action potentials in excitable cells (by
allowing outward potassium ﬂux and thus re-polarizing the plas-
ma membrane following a depolarization). Mutations and dysfunc-
tions of Kvs, typically located in excitable tissues such as the brain,
heart and skeletal muscle, have been linked to epilepsy, paralysis
and arrhythmia. Kv proteins are also expressed in non-excitable
tissues, such as kidney, lung, pancreatic islets, immune system,
adipose tissue and epithelial cells, where they also function in
feedback regulation of the plasma membrane potential, and thuschemical Societies. Published by Ehave an impact on processes ranging from secretion to cell
proliferation.
Kv channel genes can give rise to a number of different activi-
ties, via heteromultimerization. Each Kv gene encodes a peptide
subunit, four of which may form either homotetramers or hetero-
tetramers within the same family (Kv1–Kv12). Not all Kv families
produce functional ion channels on their own, but can modify
the properties of other Kv subunits by forming heterotetramers.
Further functional diversity of Kv activities can be ascribed to the
association of accessory proteins with Kv tetramers. The accessory
b-subunits are multifunctional proteins that modulate gating prop-
erties and assist association between different potassium channel
subunits. Alternative splicing and posttranslational modiﬁcations
also contribute to variety [2].
2. Voltage-gated plasma membrane potassium channels and
apoptosis
Despite the large functional diversity, voltage-gated potassium
channels belonging to different families are emerging as regulators
of programmed cell death in different cell types and tissues. Im-
paired apoptosis and/or abnormally enhanced proliferation often
cause loss of control of cell growth leading to tumor formation.
Much evidence indicates a crucial role for K+ channels in regulating
both cell growth and cell death (for review see e.g. [5–9]). Stimula-
tion of K+ channels by mitogenic factors and correlation of K+ chan-
nel activity with proliferation has been demonstrated in a varietylsevier B.V. All rights reserved.
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important for the maintenance of the cell membrane potential,
which is in turn required for the proper entry of calcium into the
cytoplasm upon stimulation of cells with a wide variety of mito-
genic factors, a prerequisite for triggering proliferation (e.g.
[11,12]). Concerning apoptosis, the Kv channel subunits known
to be involved in its regulation are diverse and include subtypes
Kv1.1, Kv1.3, Kv1.5, Kv2.1 and Kv11.1 (hERG) (see Table 1). Other
types of K+ channels, namely two-pore TWIK-related acid-sensitive
TASK-1 and TASK-3, NMDA receptors, which can mediate K+ efﬂux,
and inward rectifying Kir channels have also been implied in apop-
tosis (for review see e.g. [8]).
A common characteristic of apoptosis is a decrease in cell vol-
ume and a reduction in intracellular K+ concentration ([K+]i) (e.g.
[8,13]). This ‘apoptotic volume decrease’ (AVD), largely attributed
to K+ efﬂux, precedes hallmark apoptotic events like mitochondrial
depolarization, cytochrome c release from mitochondria, apopto-
some formation and cell fragmentation [6,14–16]. Decrease in
cytoplasmic K+ concentration, due to K+ exit during AVD, appear
to promote critical events including proteolytic cleavage of pro-
caspase-3 and enhanced endonuclease activity [16,17]. Okada
and Maeno [18] classiﬁed the apoptotic cell shrinkage into two
stages: the early volume decrease that occurs before cyt-c release
and caspase activation and the late volume decrease that occurs
concurrently with DNA fragmentation and nuclear breakage. To
drive the net efﬂux of water, which leads to cell shrinkage, release
of anions also takes place in parallel with K+ release because of the
constraint of electroneutrality. Stimulation of CD95 (Fas) receptor
has indeed been shown to induce activation of outwardly rectify-
ing Cl channels [19], which were also activated by osmotic swell-
ing [20], in Jurkat T lymphocytes. Inhibition of this chloride
channel greatly diminished apoptosis [19,21]. Elevation of extra-
cellular [K+], or treatment with K+ channel blockers such as TEA
and 4-AP have been shown to block apoptosis in various cell types
[22–24]. Activation of TEA- or 4-AP-sensitive potassium channels
is observed in neurons or pulmonary artery smooth muscle cells
at least 6 h after induction of apoptosis with staurosporine, sug-
gesting that the activation of potassium channels correlates with
late events occurring in apoptosis [22]. Interestingly, Drosophila
pro-apoptotic proteins Reaper and Grim have been shown to in-
duce stable inactivation of voltage-gated potassium channels
[25]. The conserved N-terminal sequences of Reaper and Grim
resemble the N-terminal Kv channel domain that is involved in
the inactivation of the channel. The positive correlation between
channel blocking ability and apoptotic activity of N-terminalTable 1
Effect of Kv channel modulation on apoptosis.
K+ channel
subunit
Channel modulation Effect on a
Kv1.1 Knock-down by siRNA Increased
Knock-down by siRNA Reduced a
Overexpression Reduced a
Kv1.3 Knock-down by siRNA Resistance
Knock-down by siRNA Reduced a
Expression in Kv1.3-less cells Sensitizati
Pharmacological inhibition (of Kv1.3 and TRESK
together)
Arrest of a
progressio
Kv1.5 Down-expression Reduced a
Overexpression Enhanced
Pharmacological inhibition Reduced a
Kv11.1 Increased expression Sensitizati
Pharmacological inhibition Enhanced
Kv2.1 Expression in Kv2.1-less cells Increased
Lack of functional Kv2.1 ResistanceReaper mutants indicates that the K+ channel blocking ability of
the Reaper peptide may be physiologically relevant to apoptosis.
Altogether a role for potassium channels in the regulation of
apoptosis has become clear during the last decade: activation of
potassium channels seems necessary in several systems for AVD
to occur in a relatively late phase of apoptosis, but before mito-
chondrial changes and DNA fragmentation takes place. However,
conﬂicting data also exist on this issue since inhibition of K+ chan-
nels appears to favour (e.g. [26]) and activation of K+ channels to
inhibit (e.g. [27]) apoptosis in some cell types.
Kv1.3 was one of the ﬁrst voltage-gated potassium channels re-
ported to be modulated during apoptosis [28] and was shown to
contribute to the increased K+ efﬂux underlying the late phase of
lymphocyte apoptosis [29–31]. Lack or down-regulation of expres-
sion of Kv1.3 in lymphocytes conferred resistance to apoptosis
[32,33]. Among the other Kv channels, expression of Kv1.1 was
found elevated in apoptotic cerebellar granular neurons and when
Kv1.1 was knocked-down by siRNA in the apoptotic neurons, the
neuron viability was reported to increase [34]. Rat retinal ganglion
cells (RGC) express Kv1.1, Kv1.2 and Kv1.3 and siRNAs directed
against Kv1.1 or Kv1.3 channels greatly reduced RGC death,
whereas Kv1.2-targeted siRNAs had only a small effect [35]. Inter-
estingly, Kv1.3 depletion decreased expression of caspase-3, cas-
pase-9, and Bad: molecules that exacerbate apoptotic RGC death
after axotomy. Instead, Kv1.1 depletion increased mRNA expres-
sion of Bcl-xL, an anti-apoptotic molecule that protects the mito-
chondria and is neuroprotective for injured RGCs [35]. In contrast
with the above results, Kv1.1 overexpression was recently shown
to reduce glutamate-induced hippocampal neuronal apoptosis
[36] and to attenuate neuron death resulting from glutamate tox-
icity [37]. Moreover, cromakalim, a K+ channel opener, prevents
glutamate-induced apoptosis in these cells [27]. For Kv2.1, it was
reported that expression in HEK293 increased the vulnerability of
these cells to apoptotic insult with C2-ceramide [38]. Kv2.1 has
also been implied in oxidant and staurosporine-induced apoptosis
in cortical neurons [39]. It remains to be determined whether
Kv1.1 and Kv2.1 work synergistically or independently to modu-
late glutamate-induced apoptosis in that system. In pulmonary
arterial hypertension, down-regulation of Kv1.5 has been linked
to impaired apoptosis [40]. Overexpression of Kv1.5 channel in hu-
man pulmonary artery smooth muscle cells and COS-7 cells caused
accelerated apoptotic cell shrinkage, enhanced cell apoptosis
[41,42] and its pharmacological inhibition prevented apoptosis
[41]. Interestingly, Kv1.5 has been shown to be activated by mito-
chondria-derived ROS [43] and a mitochondria-ROS-Kv1.5 axis haspoptosis Cell type References
survival Neuron [34]
poptosis Retinal ganglion cell [35]
poptosis Hippocampal neuron [36]
to apoptosis Human peripheral blood lymphocyte [33]
poptosis Retinal ganglion cell [35]
on to apoptosis Murine CTLL-2 T lymphocyte [32]
poptosis
n
Jurkat T lymphocyte [31]
poptosis Pulmonary artery smooth muscle cell [40]
apoptosis Pulmonary artery [41]
smooth muscle cell COS-7 cell [42]
poptosis COS-7 cell [41]
on to apoptosis Various tumor cell lines (SK-BR-3, HL-1, SH-
SY5Y)
[48]
apoptosis HEK-293 cell [49]
apoptosis HEK-293 cell [38]
to apoptosis Cortical neuron [39]
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species have however previously been shown to inhibit Kv channel
activities [45–47], including Kv1.5 [45], in other physiological con-
text. Finally, Kv11.1, also named hERG (human ether-a-go-go re-
lated gene) and known to be abundantly expressed in a variety
of tumor cells, has been proposed to mediate H2O2-induced apop-
tosis in various cancer cell lines [48]. Inhibition of hERG by doxaz-
osin, an antihypertensive drug, has been shown to promote
apoptosis by a not fully clariﬁed mechanism [49]. Interestingly,
the pro-apoptotic mediator cytochrome c can also activate Kv
channels while anti-apoptotic Bcl-2 inhibits them [50]. The above
described ﬁndings indicate that in many cell systems down-regu-
lation of expression of the above Kv channels confers resistance
to apoptosis while overexpression favours this process.
The crucial role of Kv channels in apoptosis and cell prolifera-
tion is underlined by a differential expression of Kv1.1, Kv1.3,
Kv1.5, Kv3.1, Kv3.4, Kv7.1, Kv7.5, Kv10.1, Kv11.1 and Kv12.2 in var-
ious tumour cells with respect to normal cells (recently reviewed
by Arcangeli et al. [9]). We report here the data regarding Kv1.3, gi-
ven that research in our groups is focussed on this channel. Kv1.3 is
known to be expressed in different tissues and cell types, in brain,
lung, thymus, spleen, lymph node, ﬁbroblasts, B lymphocytes, T
lymphocytes, tonsils, macrophages, microglia, oligodendrocytes,
osteoclasts, platelets, liver, skeletal muscle, and brown and white
fat [2]. Alizadeh et al. [51] found that the Kv1.3 gene was up-regu-
lated in activated B-like diffuse large B cell lymphoma. In human
gliomas, Kv1.3 was found to be expressed together with Kv1.5
[52]. Human breast cancer specimens showed a positive immuno-
reaction for Kv1.3 in all the examined samples [53] and Jang et al.
[54] reported that the expression level of Kv1.3 is positively corre-
lated to the stage of breast cancer (but see Brevet et al. [55] who
found that Kv1.3 is less expressed in cancerous than in normal
breast tissues). In prostate cancers Kv1.3 is mainly expressed in
early stages of progression and down-regulated in high grade can-
cers [56]. Moreover, Kv1.3, along with other Kv alpha subunits was
detected in primary human samples of colon carcinoma [57]:
immunostaining revealed higher expression in midgrade than in
high or low grade cancers [58]. Finally, Kv1.3 expression was de-
creased in pancreatic adenocarcinomas compared with normal tis-
sue and down-expression of the channel was associated with
metastatic tumors [59]. These data clearly point to a correlation
between Kv1.3 expression and tumor progression. However, the
data obtained in different systems are not coherent and the exact
underlying mechanisms of how Kv1.3 contributes to tumor pro-
gression are still unknown. It can not be excluded that, depending
on the cell type, in some cells overexpression of Kv1.3 confers a
proliferative advantage for tumor cells while in other systems
down-regulation of Kv1.3 confers resistance to apoptosis, helping
in this way tumor progression. Alternatively, high expression of
the channel might be important for the early stages with rapid pro-
liferation while apoptosis-resistance ensured by channel down-
regulation as well as by other factors is prominent in later phases
(as also suggested by the work in [56]). Further work is needed to
verify these hypotheses and to understand the exact mechanism
by which Kv1.3 contributes to tumorigenesis and/or tumor
progression.3. Kv1.3 in lymphocytes
The difﬁculties in the determination of the role of Kv1.3 in
apoptosis and tumor progression in the different tissues are par-
tially due to the fact that Kv1.3 forms mostly heterotetramers
with other channel subunits of the Kv1 family in most tissues,
and/or several other types of Kv channels co-exist in the same
tissue. In T lymphocytes, Kv1.3 forms homotetramers and is thepredominant voltage-gated potassium channel expressed in rest-
ing cells. Therefore, lymphocytes are especially useful to deﬁne
the role of Kv1.3 in physiological processes. Toxins that speciﬁ-
cally block Kv1.3 with nanomolar afﬁnity, such as scorpion toxin
margatoxin (MgTx) and sea anemone toxin ShK, have been shown
to cause plasma membrane depolarization, to reduce the [Ca2+]i
rise, and contributed importantly to establish the essential role
of Kv1.3 for lymphocyte activation [60]. Kv1.3 activity has been
identiﬁed by the group of Cahalan and Chandy as crucial during
T cell activation and proliferation (for recent review see [12]).
Blockers of Kv1.3 cause membrane depolarization, attenuate cal-
cium signalling and suppress interleukin-2 production. Accord-
ingly, speciﬁc inhibitors of Kv1.3 are emerging as very efﬁcient
immuno-suppressors for the treatment of autoimmune disorders
[61]. Kv1.3 blockers seem to be relatively safe, with slight side-ef-
fects, probably due to channel redundancy and partly because the
sensitivity of Kv1.3 homotetramers and of Kv1.3-containing het-
eromultimers may differ to these blockers. Kv1.3 has also been
shown to participate in the immunological synapse during anti-
gen presentation [62] and is part of a signalling complex that in-
cludes the tyrosine kinase p56lck (Lck) [12]. Kv1.3 can be tyrosine
phosphorylated [28,47,63,64] by p56lck, an event taking place
within 5 min after incubation of T cells by incubation with anti-
bodies against the death receptor CD95 [28] or with ceramide
[64], a sphingolipid metabolite mediating apoptosis in several
systems [65]. Ceramide treatment [64,66] and CD95 stimulation
[28] both result in tyrosine phosphorylation-dependent [28,64]
rapid inhibition of the plasma membrane-located channel. How-
ever, application of a tenfold higher dose of anti-CD95 antibody
in another study induced activation of Kv1.3 at a later time point
[30]. We have also observed a late time-point activation of Kv1.3
upon treatment of T cells with the cytostatic drug Actinomycin D
[32]. As Kv1.3 plays an important role in volume regulation [7,67]
it may be important for AVD [30]. The late activation of Kv1.3,
shown to occur downstream of caspase-8 activation, may thus
contribute speciﬁcally to events of the execution phase of apopto-
sis, i.e. cell shrinkage and reduction of the cellular potassium con-
centration, although the speciﬁc Kv1.3 inhibitor Shk did not
prevent apoptotic shrinkage [30]. Recently, an early, transient
and Margatoxin-insensitive K+ efﬂux has been observed upon
induction of apoptosis by an intrinsic mitochondrial pathway in-
ducer, staurosporine, in Jurkat T cells. A two-pore potassium
channel (TRESK) has been identiﬁed as the mediator of the early
potassium efﬂux while Kv1.3 contributed to ion efﬂux in a later
period. Inhibition of both activities resulted in arrest of apoptosis
progression [31].
For Kv1.3, a knock-out mice model is available. However, de-
spite the well-documented crucial role of Kv1.3 in lymphocyte
activation, these mice display no alterations of the immune system
and have no defects in either proliferation or apoptosis [68]. Dele-
tion of the Kv1.3 gene in Kv1.3/ mice resulted in the complete
loss of voltage-dependent potassium current in the majority of
thymocytes. But, upregulation of Kv1.1 and Kv1.4 genes, and an
approximately 50-fold increase in chloride conductance was ob-
served. This compensatory change in membrane permeability
seems to account for the apparent absence of abnormalities in
the immune responses of Kv1.3/ animals. Thus, the authors of
this work call the attention of the scientiﬁc community to interpret
studies on channel-deﬁcient mice with caution because of the pos-
sibility of compensatory channel up-regulation [68].
In order to gain genetic evidence on the role of Kv1.3 for apopto-
sis, we used interleukin-2 dependent murine cytotoxic T lympho-
cytes (CTLL-2), known to be deﬁcient for Kv1.3 [67] (CTLL-2/pJK),
and stably transfected these cells with Kv1.3 (CTLL-2/Kv1.3).
Kv1.3-expressing cells (CTLL-2/KV1.3, and genetically non-manipu-
lated Jurkat lymphocytes or activated human peripheral blood
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staurosporine, sphingomyelinase, C6-ceramide or Actinomycin D
treatment within 12 h with DNA fragmentation, cytochrome c re-
lease, mitochondrial depolarization and morphological alterations
typical of apoptosis, whereas Kv1.3-deﬁcient CTLL-2/pJK cells were
resistant in this time frame [32,33]. Importantly, CTLL-2 cells were
used as a genetic model, but ﬁndings were conﬁrmed using periph-
eral blood lymphocytes and Jurkat cells. In these latter cells down-
regulation of Kv1.3 by siRNA also severely hindered death [33]. The
observation that long incubations (24–36 h) of CTLL-2/pJK cells
with staurosporine or TNF ﬁnally result in death of CTLL-2 cells,
while at earlier time points essentially only CTLL/Kv1.3 cells under-
go apoptosis suggested that Kv1.3 functions upstream of cyto-
chrome c release and may be involved in an ampliﬁcation loop
such as the mitochondrial pathway mediating apoptosis. In T cells,
mitochondria provide a powerful, generally decisive potentiation of
the apoptotic process induced by death receptor engagement (e.g.
[69]). It is to note, that mitochondria, by regulating calcium signal-
ling, have several important actions that are relevant also to T cell
activation and function [11].4. Mitochondrial Kv1.3 and apoptosis
Multiple evidence was obtained in favour of a previously unde-
scribed mitochondrial inner membrane (IMM) localization of the
Kv1.3 in CTLL-2/Kv1.3 as well as in genetically non-manipulated
Jurkat lymphocytes [70]. The molecular identity of the channel
was assessed by comparing mitochondria isolated from the CTLL-
2 line with those from CTLL-2 cells stably transfected with Kv1.3:
Western blot, patch clamp, immunogold labelling and FACS analy-
sis indicated expression of functional Kv1.3 in mitochondria (mi-
toKv1.3) [70]. MitoKv1.3 activity was found also in mitochondria
of genetically non-manipulated Jurkat cells, indicating that the
channels’ presence in the IMM is not due to overexpression artifact
and/or mistargeting. The electrochemical gradient for K+ predicts
that K+ should enter the matrix through an IMM-located potassium
channel. Under physiological conditions, when the channel is open,
the electrophoretic ﬂux of positive charges is compensated by theFig. 1. Mitochondrial Kv1.3 is inhibited by Margatoxin. Left panel: Representative curre
conditions (134 mM K+) at +30 mV, under control condition (upper trace) and in the pre
voltage relationship of mitoKv1.3 in symmetrical conditions under control condition (ﬁll
rectangles). For experimental conditions see [70].respiratory chain-driven efﬂux of protons. Changes in volume, ex-
pected to occur upon potassium entry, under resting conditions are
compensated instead by activity of the electroneutral K+/H+ anti-
porter, leading to exit of potassium. If potassium inﬂux via mi-
toKv1.3 becomes inhibited, a hyperpolarization is expected.
Speciﬁc inhibition of mitoKv1.3 by Margatoxin and ShK induced
hyperpolarization, indicating that mitoKv1.3 is functional and
open at cca. 180 mV resting mitochondrial potential. Channel
activity could not be directly observed at such negative potential
in patch clamp experiments, but the activity observable in the
range of 60 to +60 mV applied transmembrane potential has all
characteristics of Kv1.3: a slope conductance of 25 pS, potassium
selectivity, rectiﬁcation and inhibition by speciﬁc inhibitors Mar-
gatoxin and Psora-4 (Fig. 1) [33,70]. The activity of mitoKv1.3 at
resting negative potentials (180 mV) might be due to an attenu-
ated voltage dependence and/or a marked hyperpolarizing shift in
the voltage dependence of activation (V1/2). Post-translational
modiﬁcations, cholesterol content, glycosylation and/or the ab-
sence of regulatory beta subunits might, a priori, account for the
activation of mitoKv1.3 at resting mitochondrial potential (see
e.g. [71] for lack of strong voltage dependence of Kv1.3 in the ab-
sence of beta subunit). Interestingly, Kv1.3 in mitochondria has
been identiﬁed also in other cell types, namely, in hippocampal
cells [72], in prostate cancer cell line PC3 and in breast cancer cell
line MCF-7 [73] and in macrophages ([74] and Szabò et al., unpub-
lished]), indicating that this particular Kv subunit may have a dual
localization in several different cell types. The mechanism respon-
sible for this dual localization is still unknown as is the regulatory
factor which permits activity of mitoKv1.3 at such negative poten-
tials. Whether other Kv channels may display an organellar locali-
zation is not known at the moment, but for Kv1.5 an intracellular
localization resembling the mitochondrial network has been re-
ported [75]. However, in this study the exact intracellular location
of Kv1.5 was not addressed.
The molecular identiﬁcation of the potassium conductance in T
lymphocyte mitochondria allowed us to determine a critical role of
mitoKv1.3 channel in the regulation of apoptosis at least in lym-
phocytes. In particular, expression of mitochondrially targeted
Kv1.3, shown to be functional in the inner mitochondrialnt traces recorded by patch clamp from Jurkat mitoplast under symmetrical ionic
sence of 2 nM Margatoxin (lower trace). Right panel: single open-channel current–
ed rectangles). In the presence of Margatoxin only leak current was present (empty
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cells to staurosporine-induced apoptosis [33]. A molecular mecha-
nism by which mitoKv1.3 contributes to mitochondrial apoptotic
events has also been proposed by our groups (Fig. 2). A model of
the structure of the membrane-integrated Bax monomer indicates
that at least amino acids 127 and 128, located between the ﬁfth
and sixth helices, protrude from the outer mitochondrial mem-
brane into the inter-membrane space [76]. The amino acid in posi-
tion 128 is a highly conserved, positively charged lysine, which
seem to mimic the action of the lysine in Kv1.3-blocking toxins,
which are characterized by an overall positive charge and a critical
lysine residue which partially enters the pore between subunits of
the tetrameric channel, occupying a site where K+ ions normally
bind [12]. Electrophysiological as well as pharmacological experi-
ments indicated that in mitochondria the mitoKv1.3 channel vesti-
bule faces the intermembrane space. Immunoprecipitation and
patch-clamp data showed that Bax interacts with the vestibule re-
gion of Kv1.3 and induces channel inhibition [33,73]. In particular,
physical interaction between mitoKv1.3 and Bax took place only in
cells stimulated with apoptotic signals. Wild-type Bax inhibited
Kv1.3 activity in electrophysiological experiments, while
BaxK128E mutant did not [33]. Binding of the highly speciﬁc
Kv1.3 inhibitor toxins is pH dependent and protonation of Histi-
dine 404 of Kv1.3 weakens pore-toxin interaction [12]. The IC50
of GST-Bax for Kv1.3 binding increased from 4 to 12 nM in patch
clamp experiments on T lymphocytes when the bath solution pH
was lowered to pH 6.7 and to a value 50 nM at pH 6.0. Further-
more, co-incubation of recombinant GST-Bax with GST-Kv1.3 re-
sulted in strong association of the two proteins [73]. The
strength of this interaction signiﬁcantly decreased when pH was
lowered to 6.0, further conﬁrming that Bax binds to Kv1.3 in a
manner similar to Margatoxin. Cytoplasmic Bax does not interact
with the plasmamembrane channel which displays the vestibule
region toward the extracellular environment.
Like MgTx and ShK, Bax induced a hyperpolarization of isolated
mitochondria, as measured by FACS analysis employing potential-
sensitive dyes DiOC6(3) and TMRE (tetramethylrhodamine ethylOM
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after insertion as monomer, inhibits Kv1.3 via interaction of lysine 128 with the c
hyperpolarization of the inner mitochondrial membrane (IMM). Hyperpolarization (upw
respiration and triggers production of ROS. Release of cytochrome c may be mediated by
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remodeling, also ultimately leading to cytochrome c release. The present model is based
concerning the release of cytochrome c.ester). Hyperpolarization, observed in several systems during
apoptosis, in turn results in the reduction of respiratory chain com-
ponents and in enhanced production of reactive oxygen species
(ROS) (e.g. [77,78]). ROS are able to oxidize thiol groups and thus
to elicit mitochondrial depolarization by activation of the perme-
ability transition pore (PTP) [79–81] an event correlated to cyto-
chrome c release (e.g. [82,83]). ROS have also been shown to
oxidize cardiolipin resulting in the release of cytochrome c from
the inner mitochondrial membrane [84,85]. Increase of potassium
conductance of the IMM has recently been shown to contribute to
resistance of mitochondria to calcium overload and PTP activation,
through enhanced matrix volume, independently of ROS [86]. In
our system both toxins and recombinant Bax induced increase of
ROS production by isolated mitochondria (determined by Amplex
Red assay), hyperpolarization followed by cyclosporine A-sensitive
depolarization and cytochrome c release (visualized in Western
blot) [33,70]. ROS-independent activation of PTP may take place
as well upon mitoKv1.3 inhibition. All above events, known to take
place at mitochondria in various apoptotic models, were depen-
dent on the presence of mitoKv1.3 and did not occur in mitochon-
dria of Kv1.3-deﬁcient CTLL-2/pJK cells. Bax has been shown to be
inserted into the OMM ﬁrst as monomer and then undergoing olig-
omerization [76]. Inhibition of mitoKv1.3 by presumably mono-
meric Bax is upstream of other processes, such as ROS release,
detachment of cytochrome c from the surface of the IMM, and
PTP activation. Our experiments do not contradict the view that
Bax may form oligomeric pores in the membranes or interact with
other mitochondrial proteins. Formation of Bax oligomers and pore
formation by Bax in the OMM occurs independently of the pres-
ence of mitoKv1.3 (Szabò et al., unpublished; for recent reviews
on outer membrane permeabilization see [87,88]). In summary,
cytochrome c release is dependent on the presence of mitoKv1.3
in lymphocytes, but our experiments do not address the exact
mechanism of exit of cytochrome c (Fig. 1). However, that interac-
tion between Bax and mitoKv1.3, via the lysine residue 128 in Bax,
is important in apoptosis is conﬁrmed by several observations: (1)
mutation of K128 to negatively charged glutamate residue (inions, solutes
ROS
ΔΨm
YTC
CYTCCYTC
CYTC
CYTC
S
S
PTP
ROS
ions, solutes
CYTC
Bax
conditions, permitting the ﬂux of potassium into the matrix. During apoptosis, Bax,
hannel pore vestibule, resulting in block of positive charge inﬂux and thus in
ard arrow refers to change of the potential to more negative values) interferes with
oxidation of membrane lipids (cardiolipin); subsequent exit through Bax oligomers
ight be caused by oxidation of cysteine residues. PTP opening results in membrane
lues closer to 0 mV) and might cause outer membrane rupture and/or IMM cristae
on experimental data concerning Kv1.3 obtained in our groups as well as on models
2054 I. Szabò et al. / FEBS Letters 584 (2010) 2049–2056K128E) abrogates the capacity of Bax to inhibit Kv1.3 [33]; (2) Mu-
tant K128E Bax does not induce cytochrome c release from isolated
mitochondria and its expression in double-knock-out mouse ﬁbro-
blasts does not induce apoptosis ([33] and Szabò et al., unpub-
lished) (3); preincubation of Bax with recombinant Kv1.3
prevents its effects on mitochondria [73] (4) lack of mitoKv1.3 pre-
vents Bax-induced mitochondrial changes such as depolarization
and cytochrome c release [33].
Pro- and anti-apoptotic proteins of the Bcl-2 family have been
shown to interact with other channels as well. Bcl-2 and Bcl-xL
have recently been shown to bind to IP3 receptors in the endoplas-
matic reticulum (ER) and to modulate calcium leakage from the ER
[89], suggesting the possibility of direct contacts between proteins
of the Bcl-2 family and channels. Interactions of mitochondrial
VDAC (voltage-dependent anion channel) of the outer membrane
with anti-apoptotic Bcl-xL and pro-apoptotic Bak and Bax with
consequences on cell death have also been proposed [90–92] (for
details see a recent review by Jonas [93]).
In addition to mitoKv1.3, other mitochondria-localized potas-
sium channels (for recent reviews on mitochondrial channels see
[94,95]) have received considerable attention in recent years for
their involvement in the regulation of apoptosis. Mitochondrial
potassium ﬂuxes are important for controlling the proton motive
force in energized mitochondria [77,96–98]. Potassium channel
activities or proteins identiﬁed in the inner mitochondrial mem-
brane are: (1) mKATP, an ATP-dependent channel [99], (2) big
[100] and intermediate-conductance [101] calcium-activated
potassium channels (BKCa and IKCa), (3) TASK-3 two pore potas-
sium channel [102]. Among these channels, mKATP and BKCa have
been proposed to be involved in the regulation of cell death (for re-
views on these channels see current issue by Garlid, O’Rourke, Sie-
men, Szewczyk). Interestingly, a viral protein with potassium-
conducting properties also regulates apoptosis (see Ciminale, this
issue). Whether TASK-3 is functionally expressed and whether it
regulates apoptosis is unknown. mIKCa does not seem to be impor-
tant for cell death, given that a membrane-permeable speciﬁc
inhibitor does not alter this process and Bax does not interact with
IKCa [103]. In conclusion, mitochondrial potassium conductances
are emerging key players of regulation of mitochondrial events
during apoptosis as indicated by in vitro genetic and pharmacolog-
ical data.
Interestingly, several potassium channels (Kv1.3, BKCa, IKCa
and TASK-3) found in mitochondria display a dual localization
within the cells, i.e. they are active in both the plasma membrane
(PM) and in the inner mitochondrial membrane. The exact mecha-
nism of dual localization for these channel proteins is not deﬁned
yet, but possible explanations can be put forward. Kv1.3 may end
up in mitochondria from PM lipid rafts/caveolae [104], given that
a protein trafﬁc from caveolae to ER and Golgi has been identiﬁed
[105–108]. Membrane proteins may then be transferred to mito-
chondria at ER–mitochondrion contact sites [109]. Interestingly,
the chloroplast proteome has been shown to contain N-glycosyl-
ated proteins that are transported though the endoplasmatic retic-
ulum (ER) to chloroplasts [110]. Other possibilities also exist: e.g.
minor changes in the transmembrane domain length of a viral
potassium channel was shown to be sufﬁcient to switch its locali-
zation between mitochondria and the plasma membrane [111]. Fi-
nally, these channel proteins, even though do not display a
classical N-terminal targeting sequence, may harbour an internal,
still unidentiﬁed targeting signal.5. Final remarks
Considerable amount of data point to an important involvement
of voltage-gated potassium channels in the regulation of apoptosisand tumour progression, although at present a universal correla-
tion between channel expression/activity and cell death can not
be drawn for every cell type studied so far. In the case of Kv1.3, re-
cent genetic data suggest that not only the plasma membrane-lo-
cated, but also mitochondria-located Kv1.3 contributes to the
regulation of programmed cell death. The questions whether the
role of mitoKv1.3 can be extended beyond lymphocytes and
whether other Kv channels may reside in the mitochondria and
contribute to cell death are currently being addressed in our
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